NYC Health + Hospitals/Bellevue on March 21, 2024 announced that it has received accreditation as an Academic Comprehensive Cancer Program under the American College of Surgeons (ACS) Commission on Cancer (CoC) Accreditation Program. The accreditation tells cancer patients that they will have access to the highest-quality of cancer diagnosis, care coordination, treatment, and support at the hospital. The accreditation standards supply the structure for providing all patients with a full range of services either on-site or by referral, including community-based resources. Bellevue Hospital is one of only 14 hospitals in New York State to receive accreditation at this level.
The ACS CoC is a consortium of professional organizations dedicated to improving survival and quality of life for patients with cancer. College of Surgeons accreditation is granted to institutions committed to providing high-quality cancer care by demonstrating compliance with the CoC standards. Each cancer program must undergo a rigorous evaluation and review of its performance and compliance with the CoC standards. To maintain accreditation, cancer programs must undergo a site visit every three years.
“This accreditation from the American College of Surgeons is another great milestone for our hospital as we seek the highest recognition for all the valued services we provide to the community,” said NYC Health + Hospitals/Bellevue Chief Executive Officer William Hicks. “This special designation is the result of meaningful collaboration amongst our clinical programs and thoughtful programing that ensures we are meeting all the needs of our patients through their care experience.”
“Accreditation by the American College of Surgeons Commission on Cancer is an important validation of the quality and performance of all our cancer services across all departments,” said NYC Health + Hospitals/Bellevue Chief Medical Officer Nate Link, MD, MPH. “I am grateful to the team that prepared us for this important designation and thankful to our many physicians, advanced practice providers, nurses, social workers and other Bellevue staff members who do such a great job taking care of these patients with such complex needs.”
“Our designation as an Academic Comprehensive Cancer Program underscores our commitment to the highest standards in surgical quality, optimal cancer care, and postgraduate training across multiple oncologic disciplines,” said Ann Lee, MD, FACS, Division Chief of Surgical Oncology and Chair of the Bellevue Cancer Committee. “This accreditation signifies our dedication to excellence, ensuring that all New Yorkers have access to the highest standard of cancer treatment and support, regardless of background, insurance status, or ability to pay.”
As a CoC-accredited institution, Bellevue also becomes an ACS Surgical Quality Partner. Being a Surgical Quality Partner signifies an institution’s dedication to consistently improving procedures and approaches, while maintaining a critical eye on process at every step. The Surgical Quality Partner designation lets patients know Bellevue is dedicated to quality and relentless self-improvement and has been verified or accredited by the ACS. Patients can trust that the care they receive at Surgical Quality Partner hospitals adheres to the most rigorous standards in surgical quality.
“ACS Quality programs are grounded in more than a century of experience and participation is an important measure of a hospital’s surgical quality. As an ACS Surgical Quality Partner, NYC Health + Hospitals/Bellevue has shown a commitment providing the best possible patient care, evaluating that care in a rigorous fashion, and dedicating themselves to continuous self-improvement,” said ACS Executive Director & Chief Executive Officer Patricia L. Turner, MD, MBA, FACS.
For more information about Cancer Care at NYC Health + Hospitals/Bellevue, visit https://www.nychealthandhospitals.org/bellevue/services/centers-of-excellence/cancer-center/
